What Is Genomic High-Risk Myeloma?
Although treatment of multiple myeloma has changed dramatically over time, there is still a subpopulation of patients who do not respond to treatments and are labeled as high risk. A combination of serum and genomic markers can be used to identify and stratify these patients according to association...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2022-04-01
|
| Col·lecció: | Hemato |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2673-6357/3/2/21 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|